Kindred Biosciences Inc

NASDAQ:KIN   3:59:50 PM EDT
9.11
-0.02 (-0.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)414.16M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.4 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$9.13
50-Day MA$7.55
200-Day MA$5.27
See more pivots

Kindred Biosciences Inc Stock, NASDAQ:KIN

1555 Bayshore Highway, Suite 200, Burlingame, California 94010
United States of America
Phone: +1.650.701.7901
Number of Employees: 63

Description

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.